Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected].

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

27 citing papers in PubMed.

1. Radiotherapy and temozolomide for anaplastic astrocytic gliomas.Journal of neuro-oncology · 2015
   Trial
2. MGMT Promoter Methylation Predicts Overall Survival after Chemotherapy for 1p/19q-Codeleted Gliomas.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
   Article
3. Importance of the Role of ω-3 and ω-6 Polyunsaturated Fatty Acids in the Progression of Brain Cancer.Brain sciences · 2020
   Review
4. The added prognostic value of radiological phenotype combined with clinical features and molecular subtype in anaplastic gliomas.Journal of neuro-oncology · 2019
   Article
5. The emerging role of galectins in high-fatality cancers.Cellular and molecular life sciences : CMLS · 2018
   Review
6. Identifying the association between contrast enhancement pattern, surgical resection, and prognosis in anaplastic glioma patients.Neuroradiology · 2016
   Article
7. Usefulness of PET Imaging to Guide Treatment Options in Gliomas.Current treatment options in neurology · 2016
   Article
8. Patterns of Tumor Contrast Enhancement Predict the Prognosis of Anaplastic Gliomas with IDH1 Mutation.AJNR. American journal of neuroradiology · 2015
   Article
9. Regulation of expression of O6-methylguanine-DNA methyltransferase and the treatment of glioblastoma (Review).International journal of oncology · 2015
   Review
10. Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean Radiation Oncology Group study 13-12.Journal of neuro-oncology · 2015
    Article
11. The future of high-grade glioma: Where we are and where are we going.Surgical neurology international · 2015
    Article
12. MRI grading versus histology: predicting survival of World Health Organization grade II-IV astrocytomas.AJNR. American journal of neuroradiology · 2015
    Article
13. Identifying the association of contrast enhancement with vascular endothelia growth factor expression in anaplastic gliomas: a volumetric magnetic resonance imaging analysis.PloS one · 2015
    Article
14. Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?CNS oncology · 2015
    Review
15. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis.Oncotarget · 2014
    Article
16. The impact of concurrent temozolomide with adjuvant radiation and IDH mutation status among patients with anaplastic astrocytoma.Journal of neuro-oncology · 2014
    Article
17. Case presentation - A five-year survival of the patient with glioblastoma brain tumor.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology · 2014
    Article
18. Adult brain cancer in the U.S. black population: a Surveillance, Epidemiology, and End Results (SEER) analysis of incidence, survival, and trends.Medical science monitor : international medical journal of experimental and clinical research · 2014
    Article
19. Malignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methods.Cancer management and research · 2014
    Review
20. Success at last: a molecular factor that informs treatment.Current oncology reports · 2013
    Article

Corrections and comments

• Comment on
  MGMT promoter methylation is prognostic but not predictive for outcome to adjuvant PCV chemotherapy in anaplastic oligodendroglial tumors: a report from EORTC Brain Tumor Group Study 26951.2009
• Comment on
  NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.2009
• Erratum issued

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as